Fig. 2From: Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countriesRSV-associated DALYs prior to RSV prevention and averted DALYs post-RSV prevention in 72 Gavi countriesBack to article page